Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oestrogens and cardiovascular disease.

Literature DB >> 3139216

Oestrogens and cardiovascular disease.

R Beaglehole¹.

Abstract

Entities: Disease

Mesh：

Substances：
Estrogens

Year: 1988 PMID： 3139216 PMCID： PMC1834506 DOI： 10.1136/bmj.297.6648.571

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

12 in total

1. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

Authors: P W Wilson; R J Garrison; W P Castelli
Journal: N Engl J Med Date: 1985-10-24 Impact factor: 91.245

2. Estrogen use and cardiovascular disease.

Authors: B E Henderson; R K Ross; A Paganini-Hill; T M Mack
Journal: Am J Obstet Gynecol Date: 1986-06 Impact factor: 8.661

3. Cardiovascular disease and hormone replacement treatment: a pilot case-control study.

Authors: S Adam; V Williams; M P Vessey
Journal: Br Med J (Clin Res Ed) Date: 1981-04-18

Review 4. Oral contraceptives and cardiovascular disease (first of two parts).

Authors: B V Stadel
Journal: N Engl J Med Date: 1981-09-10 Impact factor: 91.245

Review 5. Oral contraceptives and cardiovascular disease (second of two parts).

Authors: B V Stadel
Journal: N Engl J Med Date: 1981-09-17 Impact factor: 91.245

6. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

Authors: E Hirvonen; M Mälkönen; V Manninen
Journal: N Engl J Med Date: 1981-03-05 Impact factor: 91.245

7. A prospective study of postmenopausal estrogen therapy and coronary heart disease.

Authors: M J Stampfer; W C Willett; G A Colditz; B Rosner; F E Speizer; C H Hennekens
Journal: N Engl J Med Date: 1985-10-24 Impact factor: 91.245

8. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors: T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal: Circulation Date: 1987-06 Impact factor: 29.690

9. Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered.

Authors: B E Hillner; J P Hollenberg; S G Pauker
Journal: Am J Med Date: 1986-06 Impact factor: 4.965

Oestrogens and cardiovascular disease.

1. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

2. Estrogen use and cardiovascular disease.

3. Cardiovascular disease and hormone replacement treatment: a pilot case-control study.

Review 4. Oral contraceptives and cardiovascular disease (first of two parts).

Review 5. Oral contraceptives and cardiovascular disease (second of two parts).

6. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

7. A prospective study of postmenopausal estrogen therapy and coronary heart disease.

8. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

9. Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered.

10. Menopause and the risk of coronary heart disease in women.

1. Value of Dundee coronary risk-disk.

2. Hormone replacement therapy--a survey of perimenopausal women in a community setting.

Review 3. Sex steroids and cancer in older women.

4. Hormone replacement therapy: a study of women's knowledge and attitudes.